Financial News

Pfizer 4Q Revenues up 105%

Comirnaty contributes $12.5 billion in direct sales and alliance revenues in the quarter and $36.8 billion for the year.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Pfizer 4Q Revenues: $23.8 billion (+105%) 4Q Earnings: $3.4 billion (earnings were $847 million 2Q20) FY Revenues: $81.3 billion (+95%)   FY Earnings: $22.0 billion (earnings were $9.2 billion FY20) Comments: Biopharmaceuticals Group sales were $23.5 billion in the quarter, up 107%, driven by vaccine sales of $13.9 billion, up from $2.0 billion in 2Q20. Oncology sales were $3.2 billion, up 7% in the quarter. Internal Medicine sales were down 3% to $2.2 billion. Hospital sales were $1.9 bill...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters